Legal Representation
Attorney
Daniel Chalker
USPTO Deadlines
Next Deadline
128 days remaining
NOA E-Mailed - SOU Required
Due Date
June 03, 2026
Extension Available
Until December 03, 2026
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 22, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 21, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 21, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 21, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 3, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 15, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 11, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 11, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 11, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 11, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 11, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 11, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 7, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 1, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 23, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
In-vitro diagnostic preparation test kits consisting of reactants, namely, antibody, antigen, protein, peptide, pathogen, hormone, enzyme, DNA, RNA, chemical compound, aptamer, buffer solutions, and reagents for determining the presence or absence of animal, human, or plant pathogens or diseases for scientific research and agricultural purposes; Point-of-Care and triage testing products, namely, infection tests, disease testing, enzyme testing, diagnostic test patch for biosurveillance of animal, human, or plant pathogens or diseases for scientific research and agricultural purposes
Class 005
In-vitro diagnostic preparation test kits consisting of reactants, namely, antibody, antigen, protein, peptide, pathogen, hormone, enzyme, DNA, RNA, chemical compound, aptamer, buffer solutions, and reagents for determining the presence or absence of animal, human, or plant pathogens or diseases for medical purposes; Point-of-Care and triage medical testing products, namely, infection tests, disease testing, enzyme testing, diagnostic test patch for biosurveillance of animal, human, or plant pathogens or diseases for medical purposes
Class 042
Providing pathogen testing, test development, development of diagnostic computer systems and applications, and diagnostic services for others for scientific research, medical and agricultural purposes; technology advisory services relating to technical diagnostic products
Additional Information
Pseudo Mark
SOLUTION DX
Classification
International Classes
001
005
042